Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

OncoGenex Pharmaceuticals begins enrollment in OGX-427 study

Oct. 21, 2011

Novel nitroxyl-releasing agents synthesized in U.S.

Oct. 21, 2011

Kinagen claims new protein kinase inhibitors

Oct. 21, 2011

Further phase I data reported on GDC-941 in metastatic and advanced cancer

Oct. 21, 2011

Analysis of TIRASMUS data identifies possible marker of temsirolimus efficacy in colorectal cancer

Oct. 21, 2011

German research team presents new cyclin-dependent kinase 9 inhibitors

Oct. 21, 2011

FDA opens Cleveland BioLabs' IND for CBLB-502

Oct. 20, 2011

Viralytics begins enrollment in phase II Cavatak trial following approval for dosing

Oct. 20, 2011

New protein kinase inhibitors presented by GSK

Oct. 20, 2011

Phase II study assessed combination therapy containing rilotumumab in cancer

Oct. 20, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...